Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."

The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.